COMPANY

Ibex Biosciences

In addition, Ibex has successfully developed a polyclonal for the immunohistochemistry (IHC) diagnostics of cervical intraepithelial neoplasia (CIN) and skin lesions. From company website Source · Oct 12, 2026

Keywords: diagnostics

Profile checked Oct 10, 2026

1NIH grants

NIH awards 1

Annual award amounts. Total $300K.

Sep 20, 2017 NIH award 1R43CA224732-01 FY2017: $299,999 awarded for that fiscal year; activity R43 (SBIR); PI LAI, NORMAN ZHENNAN; recipient as written: IBEX BIOSCIENCES, LLC, CUMBERLAND, MD. Novel Single Chain Antibodies against source ↗